Introduction
In goats (Homeida and Cooke, 1982) and most other species (guinea-pigs, cows, ewes) in which the nonpregnant uterus has a luteolytic action (Anderson et al, 1969; Martal, 1981) , the presence of the embryo prevents luteolysis. The antiluteolyic factors secreted by sheep, goat and cattle conceptuses are closely related structurally to a-interferons (IFN-a) and are known as ovine, caprine and bovine trophoblast protein-1, respectively (Gnatek et al, 1989; Plante et al, 1990; Ott et al, 1991) . These embryonic interferons bind to IFN- receptors, have antiviral and antiproliferative properties and can influence the production of uterine PGF2a and proteins (Bazer et al, 1987; Roberts, 1989) . Intrauterine administra¬ tion of IFN-can extend the interoestrous interval and luteal lifespan in cows (Plante et al, 1991) and sheep (Stewart et al, 1992) . Significant improvement in the pregnancy rate has been observed in unilaterally ovariectomized ewes treated with IFN- (Nephew et al, 1990 ). An increase in embryonic survival and the promotion of maternal recog¬ nition of pregnancy in sheep (Schalue-Francis et al, 1991) are also among the many biological activities of trophoblast interferons.
Another process by which luteal regression is elicited in the goat is via testosterone release (Homeida and Cooke, 1984; Homeida, 1986 (Horton and Poyser, 1976) . Addition of PGF2(1 to incubations of corpora lutea increases testosterone synthesis (Shemesh et al, 1975) . Testosterone and PGF2a are released on days 13 and 14 of the oestrous cycle of goats (Homeida and Cooke, 1982, 1984) .
Recombinant bovine and ovine interferons have been shown to decrease the release of uterine PGF2(1 in vitro (Barros et al, 1990; Ott et al, 1992) and in vivo (Plante et al, 1991; Ott et al, 1992 
